MWM
FTXH icon

MinichMacGregor Wealth Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

MinichMacGregor Wealth Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-115
Closed -$3.15K – 287
2022
Q4 		$3.15K Buy
+115
New +$3.06K ﹤0.01% 524

Other funds holding FTXH

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
PPWM
Paragon Private Wealth Management Lexington, Kentucky $320M AUM 23.48% 1-Year Est. Return

MinichMacGregor Wealth Management's FTXH Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2023, closing a stake of 115 shares — an estimated $3.15K sold.

MinichMacGregor Wealth Management first reported a position in FTXH in Q4 2022 and held it in 1 quarter. The position peaked at $3.15K in Q4 2022. 31 funds tracked by Wall St. Rank hold FTXH as of Q1 2023.

  • MinichMacGregor Wealth Management reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 115 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2023, an estimated $3.15K.
  • MinichMacGregor Wealth Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and held it in 1 quarter.
  • MinichMacGregor Wealth Management's First Trust Nasdaq Pharmaceuticals ETF position peaked at $3.15K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.